Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| 1 |
Apple
AAPL
|
+$666M |
| 2 |
Meta Platforms (Facebook)
META
|
+$652M |
| 3 |
Microsoft
MSFT
|
+$469M |
| 4 |
Amazon
AMZN
|
+$383M |
| 5 |
Salesforce
CRM
|
+$373M |
Top Sells
| 1 |
HEICO Class A
HEI.A
|
+$783M |
| 2 |
Vale
VALE
|
+$398M |
| 3 |
SIVB
SVB Financial Group
SIVB
|
+$397M |
| 4 |
NBIS
Nebius Group N.V. Class A Ordinary Shares
NBIS
|
+$376M |
| 5 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
+$290M |
Sector Composition
| 1 | Technology | 20.69% |
| 2 | Healthcare | 12.92% |
| 3 | Financials | 11.76% |
| 4 | Industrials | 11.07% |
| 5 | Consumer Discretionary | 10.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2901
BioCryst Pharmaceuticals
BCRX
$1.63B
| $808K | ﹤0.01% |
96,900
-260,155
| -73% | -$2.17M |
|
2902
Novavax
NVAX
$1.41B
| $808K | ﹤0.01% |
116,570
+40,122
| +52% | +$278K |
|
2903
Funko
FNKO
$185M
| $805K | ﹤0.01% |
85,405
+23,280
| +37% | +$220K |
|
2904
Tilray
TLRY
$1.34B
| $805K | ﹤0.01% |
318,176
+193,748
| +156% | +$490K |
|
|
EIM
2905
Eaton Vance Municipal Bond Fund
EIM
$516M
| $803K | ﹤0.01% |
77,200
+26,797
| +53% | +$279K |
|
2906
Turning Point Brands
TPB
$1.84B
| $802K | ﹤0.01% |
38,197
-843
| -2% | -$17.7K |
|
2907
Bank First Corp
BFC
$1.25B
| $801K | ﹤0.01% |
10,891
+919
| +9% | +$67.6K |
|
2908
Vanguard Intermediate-Term Bond ETF
BIV
$25.3B
| $799K | ﹤0.01% |
10,410
-1,715
| -14% | -$132K |
|
|
DMO
2909
Western Asset Mortgage Opportunity Fund
DMO
$137M
| $796K | ﹤0.01% |
76,159
-4,952
| -6% | -$51.7K |
|
2910
Recursion Pharmaceuticals
RXRX
$2.1B
| $795K | ﹤0.01% |
119,215
+74,595
| +167% | +$498K |
|
2911
Sundial Growers
SNDL
$654M
| $794K | ﹤0.01% |
496,033
+448,808
| +950% | +$718K |
|
|
NAPA
2912
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $793K | ﹤0.01% |
49,905
+32,068
| +180% | +$510K |
|
2913
Forestar Group
FOR
$1.39B
| $793K | ﹤0.01% |
50,941
+13,614
| +36% | +$212K |
|
2914
Lemonade
LMND
$4.23B
| $790K | ﹤0.01% |
55,383
+24,157
| +77% | +$344K |
|
|
FSP
2915
Franklin Street Properties
FSP
$172M
| $790K | ﹤0.01% |
502,874
-796,480
| -61% | -$1.25M |
|
2916
Intrepid Potash
IPI
$384M
| $788K | ﹤0.01% |
28,553
+5,309
| +23% | +$147K |
|
|
IHD
2917
Voya Emerging Markets High Income Dividend Equity Fund
IHD
$109M
| $785K | ﹤0.01% |
146,222
-43,073
| -23% | -$231K |
|
|
ME
2918
DELISTED
23andMe Holding Co. Class A Common Stock
ME
| $785K | ﹤0.01% |
17,218
+12,993
| +308% | +$592K |
|
2919
TransAlta
TAC
$3.81B
| $785K | ﹤0.01% |
89,714
-50,617
| -36% | -$443K |
|
2920
Warby Parker
WRBY
$3.3B
| $784K | ﹤0.01% |
74,068
+39,940
| +117% | +$423K |
|
2921
InMode
INMD
$944M
| $779K | ﹤0.01% |
24,365
+10,692
| +78% | +$342K |
|
|
CERE
2922
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $778K | ﹤0.01% |
31,916
+1,263
| +4% | +$30.8K |
|
|
CATC
2923
DELISTED
CAMBRIDGE BANCORP
CATC
| $778K | ﹤0.01% |
12,001
+835
| +7% | +$54.1K |
|
2924
Oaktree Specialty Lending
OCSL
$1.2B
| $776K | ﹤0.01% |
41,368
-26,802
| -39% | -$503K |
|
2925
Nuveen Municipal Credit Opportunities Fund
NMCO
$598M
| $775K | ﹤0.01% |
67,933
-5,481
| -7% | -$62.5K |
|